Last Updated:
Name Designation Appointment Date Status
Vishnu Dutta Agrawal

Appointed as Director since June 2012

Director 14-Jun-2012 Current
Premium access

Complete director details

Unlock the complete director and KMP records available for Clyde Pharmaceutical Private Limited.

  • Complete appointment and designation records
  • Current and past company associations
  • Shareholding and remuneration where filed

Verified entity values are shown only after access is granted.

Purnima Adlakha

Appointed as Director since October 2011

Director 20-Oct-2011 Current
Kuldeep Kumar

Appointed as Director since April 2023

Director 24-Apr-2023 Current
Neelam Suri

Appointed as Director since March 2014

Director 10-Mar-2014 Current

People Timeline

Explore the timeline of key personnel in Clyde Pharmaceutical Private Limited's leadership journey.

Loading...
Contact Details
  • Address Unit No 1305, Tower-G, Fusion Homes,, Plot No Gh-05 A, Techzone-Iv,, Bishrakh Uttar Pradesh, 201306, India
  • Telephone Upgrade
  • Email Upgrade
Frequently Asked Questions
You can contact Clyde Pharmaceutical Private Limited through their registered address at Unit No 1305, Tower-G, Fusion Homes,, Plot No Gh-05 A, Techzone-Iv,, Bishrakh Uttar Pradesh, 201306, India, or via their website at clydepharma.in. Social media links are also provided where applicable.
The current directors of Clyde Pharmaceutical Private Limited are listed above in the "Current Directors & Signatories" section. You can view their names, designations, and appointment dates.
  • VISHNU DUTTA AGRAWAL
  • PURNIMA ADLAKHA
  • KULDEEP KUMAR
  • NEELAM SURI
Past director details are available under the "Past Directors & Signatories" tab. You may need to upgrade your subscription to view detailed information.
Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available